SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-284634
Filing Date
2022-11-14
Accepted
2022-11-14 16:22:55
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d410598d10q.htm   iXBRL 10-Q 1303952
2 EX-10.1 d410598dex101.htm EX-10.1 83122
3 EX-31.1 d410598dex311.htm EX-31.1 6300
4 EX-31.2 d410598dex312.htm EX-31.2 6251
5 EX-32.1 d410598dex321.htm EX-32.1 6261
  Complete submission text file 0001193125-22-284634.txt   5496896

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20220930.xsd EX-101.SCH 42946
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20220930_cal.xml EX-101.CAL 35739
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20220930_def.xml EX-101.DEF 143793
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20220930_lab.xml EX-101.LAB 350016
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20220930_pre.xml EX-101.PRE 269757
62 EXTRACTED XBRL INSTANCE DOCUMENT d410598d10q_htm.xml XML 788464
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 221385970
SIC: 2834 Pharmaceutical Preparations